The pharmaceutical industry stands at a critical crossroads. Traditional commercial engagement models are losing effectiveness in a world demanding greater personalization, digital convenience, and precision. Enter the next big disruptor: Agentic AI.
This whitepaper explores how pharma companies can transition from siloed AI applications to fully autonomous, AI-driven processes—transforming how they engage with healthcare professionals (HCPs) and patients alike.
Key Challenges Addressed
- Shrinking access to HCPs and diminishing impact of traditional sales models
- Need for seamless omnichannel experiences tailored to individual preferences
- Struggles in identifying high-potential patients early and effectively
What You’ll Discover in the Whitepaper
- A walkthrough of the AI evolution—from traditional automation to the rise of Agentic AI
- A scenario showcasing how AI agents orchestrate end-to-end engagement for a new narcolepsy therapy
- A strategic blueprint for how pharma leaders can start scaling AI through connected use cases today—paving the way for autonomous, Agentic AI-driven engagement models tomorrow.
Why It Matters
Agentic AI doesn’t just support your teams—it takes the lead. From HCP targeting to AI-powered clinical assistants and ongoing treatment monitoring, this tool unlocks:
- Higher customer engagement
- More timely and tailored decision-making
- Sustainable competitive advantage
Do you want to get "Agentic AI in Customer Engagement" as a white paper?
Then you have the chance to get the full white paper right here.
Send us your details, and we will get back to you with the full whitepaper.
We look forward to hearing from you, and should you have any questions, please reach out to us.
We look forward to hearing from you, and should you have any questions, please reach out to us.
Want to know more about Agentic AI?
Feel free to reach out to one of our consultants for an introductory session.
Mikkel Møller Andersen
Managing Director, Intellishore CH
Peter Nistrup
Head of AI